In addition, the authors showed that cristacarpin, in an in vivo experiment with a 4T1 allograft mouse mammary carcinoma model, could prevent tumor growth by inducing premature senescence through both G1 phase blocking and ROS-dependent activation of p21/waf1. This evidence concerns the gene CDKN1A and neoplasm.